United Kingdom Oncology Information Systems Market Size & Outlook, 2026-2034
United Kingdom Oncology Information Systems Market Insights
- Reed Intelligence analysis indicates that the United Kingdom Oncology Information Systems Market size, valued at USD 138.6 Million in 2025, is expected to expand to USD 270.8 Million by 2034.
- The United Kingdom market is forecasted to expand at a CAGR of 7.73% spanning 2026–2034.
- Solutions held the leading position among By Product & Service segments in 2025, based on market size.
- Professional Services is projected to post the fastest growth rate, sustaining its position as the most attractive By Product & Service segment during the forecast horizon.
![United Kingdom Oncology Information Systems Market Size, Share & Growth Report By [2034]](https://reedintelligence.com/uploads/charts/united-kingdom-oncology-information-systems-market-united-kingdom-by-product-amp-service-238422.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2025, United Kingdom held 4.39% of the global Oncology Information Systems Market size.
- By 2034, United States is anticipated to capture the largest share of the global Oncology Information Systems Market.
- In Europe, Germany is expected to lead the regional Oncology Information Systems Market size by 2034.
- Italy will remain the fastest-growing market in Europe, reaching USD 144.71 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 138.6 Million |
| Market Size In 2034 | USD 270.8 Million |
| Largest segment | Solutions |
| Units | Revenue in USD Million |
| CAGR | 7.73% (2026-2034) |
| Segmnetation Covered | |
| By Product & Service |
|
| By Application |
|
| By End-Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Oncology Information Systems Market By Product & Service 2026-2034 (USD Million)
| By Product & Service | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solutions | XX.x | XX.x | XX.x | 76.52 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Professional Services | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Kingdom Oncology Information Systems Market By Application 2026-2034 (USD Million)
| By Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Oncology | XX.x | XX.x | XX.x | 62.44 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Radiation Oncology | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Surgical Oncology | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Kingdom Oncology Information Systems Market By End-Use 2026-2034 (USD Million)
| By End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals and Diagnostic Imaging Centers | XX.x | XX.x | XX.x | 55.55 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ablation Care Centers and Cancer Care Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Government Institutions | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Research Facilities | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.